Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1.

BACKGROUND The pathogenesis of influenza A virus subtype H5N1 (hereafter, "H5N1") infection in humans is not completely understood, although hypercytokinemia is thought to play a role. We previously reported that most H5N1 viruses induce high cytokine responses in human macrophages, whereas some H5N1 viruses induce only a low level of cytokine production similar to that induced by seasonal viruses. METHODS To identify the viral molecular determinants for cytokine induction of H5N1 viruses in human macrophages, we generated a series of reassortant viruses between the high cytokine inducer A/Vietnam/UT3028II/03 clone 2 (VN3028IIcl2) and the low inducer A/Indonesia/UT3006/05 (IDN3006) and evaluated cytokine expression in human macrophages. RESULTS Viruses possessing the acidic polymerase (PA) gene of VN3028IIcl2 exhibited high levels of hypercytokinemia-related cytokine expression in human macrophages, compared with IDN3006, but showed no substantial differences in viral growth in these cells. Further, the PA gene of VN3028IIcl2 conferred enhanced virulence in mice. CONCLUSIONS These results demonstrate that the PA gene of VN3028IIcl2 affects cytokine production in human macrophages and virulence in mice. These findings provide new insights into the cytokine-mediated pathogenesis of H5N1 infection in humans.

[1]  Y. Guan,et al.  H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. , 2011, The Journal of infectious diseases.

[2]  H. Goto,et al.  Reassortment between Seasonal H1N1 and Pandemic (H1N1) 2009 Influenza Viruses Is Restricted by Limited Compatibility among Polymerase Subunits , 2011, Journal of Virology.

[3]  Ryo Takano,et al.  Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. , 2011, The Journal of general virology.

[4]  S. Akira,et al.  Influenza A Virus Polymerase Inhibits Type I Interferon Induction by Binding to Interferon β Promoter Stimulator 1* , 2010, The Journal of Biological Chemistry.

[5]  Yoshihiro Kawaoka,et al.  Induction of TNF-α in human macrophages by avian and human influenza viruses , 2010, Archives of Virology.

[6]  P. Woo,et al.  Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies , 2010, The Journal of infectious diseases.

[7]  Nancy Y. Ip,et al.  Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages , 2009, PloS one.

[8]  Y. Guan,et al.  Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. , 2009, The Journal of infectious diseases.

[9]  Wang Guansong,et al.  Update on avian influenza A (H5N1) virus infection in humans , 2009 .

[10]  A. Tomoiu,et al.  Host restriction of avian influenza viruses at the level of the ribonucleoproteins. , 2008, Annual review of microbiology.

[11]  D. Hui.  Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection , 2008, Respirology.

[12]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[13]  Thijs Kuiken,et al.  H5N1 Virus Attachment to Lower Respiratory Tract , 2006, Science.

[14]  J. Farrar,et al.  Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. , 2005, The New England journal of medicine.

[15]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[16]  R. Webster,et al.  H5N1 influenza: a protean pandemic threat. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[18]  K. Yuen,et al.  Peiris, J.S.M. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617−619 , 2004 .

[19]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[22]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[24]  A. Ishihama,et al.  The molecular anatomy of influenza virus RNA polymerase. , 1997, Biological chemistry.

[25]  P. Palese,et al.  Determination of influenza virus proteins required for genome replication , 1990, Journal of virology.

[26]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .